Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
![Insider Trading Transactions for Janux Therapeutics Inc.](/ichart-1817713-930-180-60.png)
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-03 Sale | 2024-06-05 7:25 pm | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 1,500,000 | $54.75 | $82,125,000 | 3,344,601 (Indirect Direct) | View |
2024-06-03 Sale | 2024-06-05 7:23 pm | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer | 822,721 | $54.75 | $45,043,975 | 3,515,007 (Indirect Direct) | View |
2024-06-03 Sale | 2024-06-05 7:19 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. 10% Owner | 1,500,000 | $54.75 | $82,125,000 | 6,611,234 (Indirect Direct) | View |
2023-11-13 Purchase | 2023-11-15 4:48 pm | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 849,854 | $5.87 | $4,988,643 | 5,329,346 (Indirect) | View |
2023-11-13 Purchase | 2023-11-15 4:46 pm | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect) | View |
2023-11-13 Purchase | 2023-11-13 7:11 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner | 849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect Direct) | View |
2023-07-19 Purchase | 2023-07-21 4:31 pm | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 495,008 | $12.46 | $6,167,800 | 9,668,878 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-19 Option Award(A) | 2024-07-24 8:00 pm | N/A 2034-07-18 | Janux Therapeutics Inc. | JANX | DOBMEIER ERIC Director | 5,342 | $0 | 10,342 (Direct) | View |
2024-07-19 Option Award(A) | 2024-07-24 8:00 pm | N/A 2034-07-18 | Janux Therapeutics Inc. | JANX | Hernday Natasha Director | 5,342 | $0 | 10,342 (Direct) | View |
2024-07-19 Option Award | 2024-07-22 8:04 pm | N/A 2034-07-18 | Janux Therapeutics Inc. | JANX | DOBMEIER ERIC Director | 32,550 | $0 | 32,550 (Direct) | View |
2024-07-19 Option Award | 2024-07-22 8:03 pm | N/A 2034-07-18 | Janux Therapeutics Inc. | JANX | Hernday Natasha Director | 32,550 | $0 | 32,550 (Direct) | View |
2024-06-26 Option Award | 2024-06-28 4:35 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 10,850 | $0 | 9,176,502 (Indirect) | View |
2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 10,850 | $0 | 7,260,340 (Direct) | View |
2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | McNulty Alana B. Director | 10,850 | $0 | 10,850 (Direct) | View |
2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | Kung Winston Director | 10,850 | $0 | 10,850 (Direct) | View |
2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director | 10,850 | $0 | 118,878 (Direct) | View |
2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | Barrett Ronald W Director | 10,850 | $0 | 10,850 (Direct) | View |
2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | Simson Jake Director | 10,850 | $0 | 10,850 (Direct) | View |
2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director | 10,850 | $0 | 76,393 (Direct) | View |
2024-02-29 Other | 2024-03-04 7:31 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner | 1,016,200 | $0 | 5,009,239 (Direct) | View |
2024-02-29 Other | 2024-03-04 4:44 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director | 2,986 | $0 | 111,014 (Direct) | View |
2024-02-29 Other | 2024-03-04 4:33 pm | N/A N/A | Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director | 1,493 | $0 | 67,036 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 4:54 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 111,000 | $0 | 111,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 4:53 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer | 151,500 | $0 | 151,500 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 4:52 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner | 157,000 | $0 | 157,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 4:50 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 105,000 | $0 | 105,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 4:49 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 356,500 | $0 | 356,500 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 4:47 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer | 147,000 | $0 | 147,000 (Direct) | View |
Ownership | 2024-01-03 4:45 pm | N/A N/A | Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer | 0 | $0 | 746,332 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:15 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 12,500 | $0 | 12,500 (Indirect) | View |
2023-06-14 Option Award | 2023-06-16 5:10 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:09 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | McNulty Alana B. Director | 12,500 | $0 | 12,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:08 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Simson Jake Director | 12,500 | $0 | 12,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:08 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Kung Winston Director | 12,500 | $0 | 12,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:07 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director | 12,500 | $0 | 12,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:06 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director | 12,500 | $0 | 12,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:06 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Barrett Ronald W Director | 12,500 | $0 | 12,500 (Direct) | View |